Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tacni 1mg capsules
0802020T0BGABAB
|
Tacni | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacni 5mg capsules
0802020T0BGACAA
|
Tacni | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacrolimus 0.0001% mouthwash
0802020T0AAAXAX
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacrolimus 25mg/5ml oral liquid
0802020T0AAASAS
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacrolimus 2mg suppositories
0802020T0AABIBI
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacrolimus 2mg/5ml oral suspension
0802020T0AAAKAK
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacrolimus 500micrograms/5ml oral suspension
0802020T0AAARAR
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacrolimus 5mg/1ml solution for infusion ampoules
0802020T0AAACAC
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacrolimus 750microgram modified-release tablets
0802020T0AABDBD
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacrolimus 800micrograms/5ml oral solution
0802020T0AABABA
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Tacrolimus 900micrograms/5ml oral suspension
0802020T0AABBBB
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Vivadex 0.5mg capsules
0802020T0BFACAF
|
Vivadex | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Vivadex 1mg capsules
0802020T0BFABAB
|
Vivadex | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Vivadex 5mg capsules
0802020T0BFAAAA
|
Vivadex | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.